KIMBERLEY BURGESS: Open Payments
NPI 1932120466 · ALTAMONT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 23 payments from 10 companies in 2025. Trend: 2023 $1,046 · 2024 $286 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $160 |
| Novo Nordisk Inc | 1 | $102 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| Lilly USA, LLC | 3 | $50 |
| ABBVIE INC. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Viatris Specialty LLC | 2 | $35 |
| PFIZER INC. | 2 | $33 |
| Exact Sciences Corporation | 1 | $26 |
| Amgen Inc. | 1 | $18 |
Products named: Wegovy, AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, QULIPTA, JARDIANCE, YUPELRI, NURTEC ODT.
Industry payments across IL — which companies pay providers there.
